EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Inflammation in cancer cachexia: still the central tenet or just another player?

Noemi Iaia iD, Chiara Noviello iD, Maurizio Muscaritoli, Paola Costelli iD

American Journal of Physiology-Cell Physiology · 01.06.2025 · 328 (6) · C1837-C1852

DOI: 10.1152/ajpcell.00808.2024 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.06.2025. Verfasst von Noemi Iaia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Biological Sciences, University of Turin, Turin, Italy. Hauptthemen laut MEDLINE: Cachexia, Neoplasms, Inflammation, Inflammation Mediators. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 167 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer cachexia, a multifactorial syndrome characterized by body weight loss, muscle, and adipose tissue wasting, affects patients with cancer. Over time, the definition of cachexia has been modified, including inflammation as one of the main causal factors. Evidence has suggested that a range of proinflammatory mediators may be involved in the regulation of intracellular signaling, resulting in enhanced resting energy expenditure, metabolic changes, and muscle atrophy, all of which are typical features of cachexia. Physiologically speaking, however, inflammation is a response aimed at facing potentially damaging events. Along this line, its induction in the cancer hosts could be an attempt to restore the physiological homeostasis. Interesting observations have shown that cytokines such as interleukins 4 and 6 could improve muscle wasting, supporting the view that the same mediator may exert pro- or anti-inflammatory activity depending on the immune cells involved as well as on the tissue metabolic demand. In conclusion, whether inflammation is crucial to the occurrence of cachexia or just one contributor among others, is still unclear. Indeed, while inflammation is a trigger of cachexia, the alterations of energy and protein metabolism and of the hormonal homeostasis occurring in cachexia likely act as inflammatory stimuli on their own. Whether the causative role prevails over the compensatory one likely depends on the tumor type and stage, patient lifestyle, the presence of comorbidities, and the response to anticancer treatments paving the way to a holistic, personalized approach to cancer cachexia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CachexiaNeoplasmsInflammationInflammation MediatorsHumansAnimalsEnergy MetabolismMuscular AtrophyCytokines

Stichwörter der Autor:innen

cachexiacancercytokinesinflammationskeletal muscle

Substanzen

Inflammation MediatorsCytokines

Autor:innen und Institutionen

  • Department of Clinical and Biological Sciences, University of Turin, Turin, Italy.
  • Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Department of Translational Medicine, Sapienza University of Rome, Rome, Italy.

ORCID-Profile: Noemi Iaia, Chiara Noviello, Paola Costelli

Zitieren

APA

Iaia, N., Noviello, C., Muscaritoli, M., & Costelli, P. (2025). Inflammation in cancer cachexia: still the central tenet or just another player?. American Journal of Physiology-Cell Physiology, 328(6), C1837-C1852. https://doi.org/10.1152/ajpcell.00808.2024

Vancouver

Iaia N, Noviello C, Muscaritoli M, Costelli P. Inflammation in cancer cachexia: still the central tenet or just another player?. American Journal of Physiology-Cell Physiology. 2025;328(6):C1837-C1852. doi:10.1152/ajpcell.00808.2024

BibTeX
@article{Iaia2025,
  author = {Iaia, Noemi and Noviello, Chiara and Muscaritoli, Maurizio and Costelli, Paola},
  title = {Inflammation in cancer cachexia: still the central tenet or just another player?},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2025},
  volume = {328},
  number = {6},
  pages = {C1837--C1852},
  doi = {10.1152/ajpcell.00808.2024}
}
Kostenlos starten →